The modifying effects of adiposity on the cardiovascular safety of sulphonylureas. Suissa K, Schneeweiss S, Douros A, Filion KB, et al. Diabetes Obes Metab 2021;23:2502-2512.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Suissa K, Schneeweiss S, Douros A, Filion KB, et al. The modifying effects of adiposity on the cardiovascular safety of sulphonylureas. Diabetes Obes Metab 2021;23:2502-2512.
PMID: 34251086